BioLargo, Inc. Reports Unaudited Revenue Results for the Fourth Quarter and Year Ended December 31, 2020
January 25, 2021 at 07:12 am
Share
BioLargo, Inc. reported unaudited revenue results for the fourth quarter and year ended December 31, 2020. For the quarter, the company generated approximately $900,000 in company-wide revenue, a 36% increase compared to the prior quarter.
In the year ended December 31, 2020, BioLargo generated approximately $2.4 million in revenue, a 31% increase compared to the previous year.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental segment engaged in selling odor and volatile organic control products and services. Clyra Medical segment develops and sells medical products based on its technologies. BLEST segment provides professional engineering services on a time and materials basis for outside clients and supports its internal operations as needed. Its Canada segment is the main hub of its scientists researching and developing its technologies. Its BETI segment is engaged in developing its proprietary battery technology. BEST segment manages the sales and distribution of its water treatment products and related services.
BIOLARGO, INC. 
